Immunoprecise Antibodies Ltd IPA

Technology Scientific & Technical Instruments

ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from the United States of America.

NDAQ:IPA - Post by User

Immunoprecise Antibodies Ltd

<< Previous

Bullboard Posts

Next >>

Post by cleareyeon Dec 13, 2021 9:00am

119 Views

Post# 34224365

Q2 results out

Summary:

Second Quarter Fiscal Year 2022 Financial Summary*

The Company achieved revenues of $4.7 million, a decrease of $32,780 or (0.7%) from the same period last year**.
The Company, primarily through its subsidiary Talem Therapeutics LLC, invested $2.8 million in strategic research and development costs compared to $1.1 million in the same period last year.
The Company recorded a net loss of $5.0 million during the three months ended October 31, 2021, compared to net loss of $463,584 for the three months ended October 31, 2020.
Adjusted EBITDA*** was a loss of $2.9 million, as compared to positive EBITDA of $795,159 for the same period last year.
As of October 31, 2021, the Company held cash of $38.4 million.